期刊文献+

植入型心律转复除颤器在遗传性心律失常患者中的应用及术后随访 被引量:3

Implantable cardioverter defibrillator in patients with inherited cardiac arrhythmias
原文传递
导出
摘要 目的了解因遗传性心律失常植入心律转复除颤器(ICD)的患者术后情况及ICD的治疗效果。方法回顾性分析阜外医院从2004年6月到2011年6月诊断为长QT综合征、Brugada综合征、致心律失常性右心室心肌病(ARVC)以及肥厚型心肌病并且植入了ICD的全部患者,通过定期随访及调阅患者的ICD内存储的数据了解患者术后的一般情况、ICD植入术后室性心律失常的发作情况以及ICD的工作情况。结果共入选患者43例,其中男25例,女18例,年龄8—78(41.5±15.8)岁,随访8~84(37.0±20.6)个月。21例(48.8%)患者在随访期内发生室性心动过速/心室颤动(室速/室颤)事件,其中有5例(11.6%)患者发生的室速/室颤事件属于不恰当识别。1例患者在植入ICD后发生未识别事件。ICD共记录到室速/室颤事件382次,植入ICD后首次发生室速/室颤事件的时间为术后1~36(6.4±8.9)个月,84.6%的室速/室颤事件发生于1年内。ICD共启动治疗程序498次,包括抗心动过速起搏381次,同步电复律83次,高能量除颤34次。结论遗传性心律失常患者恶性室性心律失常复发率高且复发早。二级预防植入ICD可有效预防患者猝死的发生。 Objective To investigate the efficacy of implantable cardioverter defibrillator(ICD) in patients with inherited cardiac arrhythmias. Methods A retrospective analysis was conducted in patients with Long-QT syndrome (LQTS), Brugada syndrome, hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy (ARVC) who received ICDs between June 2004 and June 2011 in Fuwai Hospital. Results Fourty-three patients (58% male, age 41.5 ± 15.8 years)were included. During the follow-up period of (37.0±20. 6) months, a total of 382 episodes of malignant ventricular arrhythmias were documented in 21 patients (48.8%) ,while 5 (11.6%)of whom due to inappropriate detection. One patient had a sustained ventricular tachycardia episode undetected but not leading to a severe event. The average duration from implantation to first malignant ventricular arrhythmias episode was 6.4±8. 9 months. The cumulative event rate was 84. 6% at 1 year follow-up. ICDs delivered 4-98 therapies, consisting of 381 times of ATP, 83 times of CV, and 34 times of SHOCK. Conclusions Patients with inherited cardiac arrhythmias have a high recurrence rate of ventricular malignant arrhythmias, and ICD is effective in preventing these patients from sudden cardiac death. However, inappropriate detection/therapy is an outstanding problem in this population.
出处 《中华心律失常学杂志》 2012年第3期176-179,共4页 Chinese Journal of Cardiac Arrhythmias
关键词 植入型心律转复除颤器 心脏性猝死 随访 离子通道病 心肌病 Implantable cardioverter defibrillator Sudden cardiac death follow-up Channelopathy Cardiomyopathy
  • 相关文献

参考文献19

  • 1Heidenreich PA, Keeffe B, McDonald KM, et al. Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death. Am Heart J,2002,144:422-430.
  • 2Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg(CASH). Circulation ,2000,102:748-754.
  • 3华伟,张澍,牛红霞,陈柯萍,王方正,陈新.植入型心律转复除颤器在心脏性猝死一级和二级预防中的应用——全国31家医院植入型心律转复除颤器植入适应证分析[J].中华心律失常学杂志,2010,14(1):9-11. 被引量:7
  • 4Klein RC, Raitt MH, Wilkoff BL, et al. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators ( AVID ) Trial. J Cardiovasc Electrophysiol, 2003,14:940-948.
  • 5华伟,张澍,王方正,唐闽,陈柯萍,牛红霞,陈若涵,陈新.植入型心律转复除颤器抗心动过速起搏治疗室性心动过速疗效评价[J].中华心律失常学杂志,2005,9(5):341-343. 被引量:13
  • 6王方正,张澍,任自文,郭继鸿,胡大一,陈新,中华医学会心电生理和起搏分会及中国生物医学工程学会心脏起搏与电生理分会ICD专家工作组.植入型心律转复除颤器治疗的适应证[J].中华心律失常学杂志,2002,6(4):198-206. 被引量:29
  • 7Proclemer A, Ghidina M, Facchin D, et al. Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6. Pacing Clin Electrophysiol, 2009,32:434-445.
  • 8Watkins H ,Ashrafian H, Redwood C, et al. Inherited cardiomyopathies. N Engl J Med,2011,364 : 1643-1656.
  • 9Roguin A,Bomma CS, Nasir K, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coil Cardiol,2004,43:1843-1852.
  • 10Bhonsale A, James CA,Tichnell C, et al. Incidence and predictors of implantable cardioverter-defibriliator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coil Cardiol,2011,58 :1485-1496.

二级参考文献94

  • 1王方正,华伟,陈新.经静脉胸前植入单导线植入型心律转复除颤器[J].中华心律失常学杂志,1997,1(1):6-9. 被引量:13
  • 2王方正.中国心脏起搏事业40年[J].中华心律失常学杂志,2005,9(3):166-171. 被引量:10
  • 3李宁,浦介麟.钙离子通道基因异常与室性心律失常[J].中国心脏起搏与心电生理杂志,2006,20(1):8-12. 被引量:8
  • 4王方正,张澍,华伟,胡大一,陈新.全国心脏起搏器临床应用调查(2002至2005年)[J].中华心律失常学杂志,2006,10(6):475-478. 被引量:21
  • 5Hua W, Zhang LF, Wu YF, et al. Incidence of sudden cardiac death in China:analysis of 4 regional populations. J Am Coil Cardiol,2009,54 : 1110-1118.
  • 6Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices : summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation,2002,106 : 2145-2161.
  • 7The Antiarrhythmics versus Implantable Defibrillators (AVID) In- vestigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med,1997,337: 1576-1583.
  • 8Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation ,2000,102 : 748-754.
  • 9Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 2000, 101: 1297-1302.
  • 10Bigger JT Jr,for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med,1997,337: 1569- 1575.

共引文献61

同被引文献19

  • 1王方正,张澍,华伟,胡大一,陈新.全国心脏起搏器临床应用调查(2002至2005年)[J].中华心律失常学杂志,2006,10(6):475-478. 被引量:21
  • 2Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Ab- normalities:a report of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines. ( Writ- ing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol,2008,51 : e1-62.
  • 3Dickstein K,Vardas PE,Aurlcchio A, et al. 2010 focused update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribu- tion of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail,2010,12 : 1143-1153.
  • 4McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute mad chronic heart failure 2012. Eur J Heart Fail,2012,14 : 803- 869.
  • 5Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert con- sensus on the monitoring of Cardiovascular Implantable Electronic Devices (CIEDs) : Description of techniques, indications, person- nel, frequency and ethical considerations. Europace, 2008, 10: 707-725.
  • 6Haycs DL, Naccarelli GV, Fuman S, et al. North American Society to Pacing and Electrophysiology. NASPE training requirements for cardiae implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Eleetrophysiol,2003,26 : 1556-1562.
  • 7Naccarelli GV,Conti JB, DiMarco JP,et al. 2008 COCATS 3 Tack Force 6: training in specialized electrophysiology,cardiac pacing, and arrhythmia management. Heart Rhythm ,2008,5:332-337.
  • 8Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol, 2005,28 : 235 -240.
  • 9Joseph GK, Wilkoff BL, Dresing T, et al. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol,2004,11 : 161-166.
  • 10Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of au- tomatic remote monitoring for implantable cardioverter-defibrilla- tot follow-up: The Lumos-T Safely Reduces Routine Office De- vice Follow-up (TRUST) trial. Circulation,2010,122:325-332.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部